Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
biochemical pharmacology; biomarkers; biosynthetics; chromosome; DNA structure; epigenetics; genetics; genomics; histology; individually tailored therapy; medicinal chemistry; medicine; membrane proteins; membrane transport; molecular biology; molecular pharmacology; pathophysiology; pharmacy; physiology; population genetics; proteomics; RNA structure; signal transduction; stem cells; transcriptional analyses; transgenic techniques; translational analyses
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Phytochemicals for Diabetes (Deadline: 30 April 2026)
- Preservation of Testicular Function: From Andrological Pathologies to Testis Cancer (Deadline: 30 April 2026)
- Multi-Target and Synergistic Therapeutic Strategies in Modern Drug Discovery (Deadline: 30 April 2026)
- Natural Compounds in Cancer Therapy and Prevention, 2nd Edition (Deadline: 20 May 2026)
- Antituberculous Drugs: Progress and Challenges (Deadline: 20 May 2026)
- New Anti-cancer Agents: Design, Synthesis and Applications (Deadline: 20 May 2026)
- Molecular Pharmacological Advances in Gastrointestinal Health (Deadline: 20 May 2026)
- Pharmacology and Toxicology of Synthetic and Natural Products (Deadline: 20 May 2026)
- New Advances in Opioid Research (Deadline: 20 May 2026)
- Molecular Research on Potential New Antidepressant Drugs (Deadline: 20 May 2026)
- New Insights in Artificial Intelligence for Drug Design and Target Discovery (Deadline: 20 May 2026)
- Advances in Organic Synthesis in Drug Discovery (Deadline: 20 May 2026)
- From Nature to Medicine: Exploring Natural Products for New Therapies (Deadline: 20 May 2026)
- Molecular Pharmacology of Cation-Permeable Ion Channels (Deadline: 20 May 2026)
- Structural Characterization and Pharmacological Activity of Natural Compounds (Deadline: 20 May 2026)
- New Advances in Reversing Cancer Therapy Resistance (Deadline: 20 May 2026)
- Targeted Protein Degradation: From Molecular Mechanisms to Therapeutic Applications (Deadline: 20 May 2026)
- New Insights into Chemotherapeutic Agents in Cancer Treatment (Deadline: 20 May 2026)
- Antiviral Drug Targets: Structure, Function, and Drug Design—3rd Edition (Deadline: 20 May 2026)
- Molecular Computational Research in Pharmacological Structure–Efficacy (Deadline: 20 May 2026)
- Enzyme Inhibitory Assessment and Molecular Docking Studies of Natural and Synthetic Heterocyclic Compounds (Deadline: 20 May 2026)
- Design, Synthesis, and Biological Evaluation of Novel Bioactive Compounds (Deadline: 30 May 2026)
- Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity, 3rd Edition (Deadline: 31 May 2026)
- The Future of Drug Discovery and Development, 2nd Edition (Deadline: 31 May 2026)
- Advances in the Pharmacology of Depression and Mood Disorders (Deadline: 31 May 2026)
- Curcumin Derivatives and Curcuminoids with Potential Biomedical Applications (Deadline: 31 May 2026)
- Drug Treatment for Bacterial Infections: 2nd Edition (Deadline: 31 May 2026)
- Synthesis and Activity Studies of Anticancer Compounds (Deadline: 31 May 2026)
- Advancements in Diagnostic and Preventive Pharmacogenomics (Deadline: 20 June 2026)
- Natural Products and Synthetic Compounds for Drug Development: 3rd Edition (Deadline: 20 June 2026)
- Pharmacokinetics of Psychoactive Substances: Molecular and Forensic Aspects (Deadline: 20 June 2026)
- Glycoconjugates: From Structure to Therapeutic Application (Deadline: 20 June 2026)
- The Role of Bioactive Natural Products in Human Health (Deadline: 20 June 2026)
- Natural Bioactive Compounds for Human Health, 3rd Edition (Deadline: 20 June 2026)
- Recent Advances in Computer-Aided Drug Design (Deadline: 20 June 2026)
- Molecular Modeling in Pharmaceutical Sciences (Deadline: 20 June 2026)
- Anticancer Drugs: Current Status and Future Directions (Deadline: 20 June 2026)
- Anti-Cancer Effects of Natural Products: 2nd Edition (Deadline: 20 June 2026)
- Emerging Strategies in Tuberculosis Drug Discovery (Deadline: 20 June 2026)
- Network Pharmacology: An Emerging Field in Drug Discovery (2nd Edition) (Deadline: 20 June 2026)
- New Progress in Peptide Drugs (Deadline: 30 June 2026)
- Molecular Discoveries in Pharmacogenetics: From Bench to Bedside (Deadline: 30 June 2026)
- From Drug Design to Mechanistic Understanding and Resistance (Deadline: 30 June 2026)
- The Role of Natural Products in Drug Discovery: 2nd Edition (Deadline: 30 June 2026)
- Applications and Advances of Organic Synthesis in the Design of Antiparasitic, Antiviral, and Anticancer Drugs (Deadline: 30 June 2026)
- Recent Advances in Natural Products for Antiviral Drug Discovery (Deadline: 30 June 2026)
- Effect of Molecular Structure on the Distribution, Pharmacokinetics, and Metabolic Transformation of Bioactive Compounds (Deadline: 30 June 2026)
- Advances and Emerging Trends in Marine Natural Products (Deadline: 20 July 2026)
- Anticancer, Antioxidant, and Anti-Inflammatory Properties of Natural Products (Deadline: 20 July 2026)
- Antibacterial Activity of Novel Antimicrobial Agents (Deadline: 20 July 2026)
- Drug Delivery Systems in Veterinary Medicine: Innovations and Applications (Deadline: 20 July 2026)
- G Protein-Coupled Receptors: Signaling, Regulation and Therapeutic Opportunities, 2nd Edition (Deadline: 20 July 2026)
- In Silico Approaches to Unravelling Toxicity Mechanisms in Molecular Drugs (Deadline: 20 July 2026)
- Molecular Insight into Antimicrobial Resistance (Deadline: 20 July 2026)
- 25th Anniversary of IJMS: Updates and Advances in Molecular Pharmacology (Deadline: 20 July 2026)
- Small Molecules and Antibodies for Targeted Cancer Therapies (Deadline: 20 July 2026)
- Natural Products for Cancer: Cutting-Edge Trends and Future Directions (Deadline: 30 July 2026)
- Computational and Synthetic Approaches in Drug Design: Novel Methodologies and Applications (Deadline: 30 July 2026)
- Mechanistic and Small Molecule Discoveries for Therapeutic Advances in Hypertrophic and Dilated Cardiomyopathies (Deadline: 31 July 2026)
- From Natural Products to Synthetic Small-Molecule Antioxidants: Mechanistic and Kinetic Foundations for Drug Discovery (Deadline: 31 July 2026)
- Beyond Solid-State Drugs: Liquid-State Pharmaceutical Re-Engineering—from Molecular Design to Delivery Performance (Deadline: 31 July 2026)
- Microfluidic Organ-on-a-Chip: Bridging Drug Discovery to Precision Medicine (Deadline: 31 July 2026)
- Breaking the Shield: New Insights in Overcoming Bacterial Resistance (Deadline: 31 July 2026)
- Pharmacological Mechanisms of Natural Products: Biological Targets and Clinical Perspectives (Deadline: 31 July 2026)
- Cellular Stress, Metabolic Disorders and Cardiovascular Diseases: From Molecular Mechanisms to Integrative Pharmacology (Deadline: 31 July 2026)
- Anti-Cancer Drugs: Natural Products, Synthetic Compounds and Potential Pharmacological Effects and Applications (Deadline: 20 August 2026)
- Innovative Strategies in the Design and Development of Anticancer Agents (Deadline: 20 August 2026)
- Lipopolysaccharide as a Drug Target (Deadline: 20 August 2026)
- Synthesis and Structural Studies of Potential Anticancer Drugs (Deadline: 20 August 2026)
- Ion Channels as Therapeutic Target: Drug Design and Pharmacological Investigation (3rd Edition) (Deadline: 20 August 2026)
- The Medicinal Value of Plant Extracts (Deadline: 20 August 2026)
- Advances in Anticancer Drug Discovery: Design, Synthesis and Molecular Insights (Deadline: 20 August 2026)
- Recent Advances of Novel Pharmaceutical Designs for Anticancer Therapies, 4th Edition (Deadline: 25 August 2026)
- Latest Advances in Antiparasitic Agents (Deadline: 30 August 2026)
- Cell Penetrating Peptides: Novel Therapeutic Tools for Drug Delivery (Deadline: 31 August 2026)
- Design, Synthesis and Evaluation of Anticancer Agents (Deadline: 31 August 2026)
- Exploring Melatonin and Related Indolic Agents (Deadline: 31 August 2026)
- Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 4rd Edition (Deadline: 31 August 2026)
- Artificial Intelligence in Drug Design: Molecular Aspects (Deadline: 31 August 2026)
- Design of Therapeutic Small-Molecular Blockers Against Channel Proteins (Deadline: 31 August 2026)
- Antibiotic Resistance: Recent Developments and Future Prospects (Deadline: 31 August 2026)
- Mechanistics Insights in Antidepressants: Charting New Pathways for Future Research (Deadline: 31 August 2026)
- Drug Discovery and Development for Renal Disease Treatment (Deadline: 20 September 2026)
- Cancer Drug Treatment and Cancer Cell Drug Resistance (Deadline: 20 September 2026)
- Drugs—from Chemical Structure to Biological Activity (Deadline: 20 September 2026)
- Biosynthesis of Phytochemicals and Their Applications in Novel Drug Lead Development (Deadline: 20 September 2026)
- Molecular Pharmacology of Protein Kinase Inhibitor (Deadline: 20 September 2026)
- Advanced Research in Veterinary Drugs (Deadline: 20 September 2026)
- Advances in Drug Synthesis Reactions: From Bench to Breakthroughs (Deadline: 20 September 2026)
- Natural Products and Compounds in Anticancer Drug Discovery (Deadline: 20 September 2026)
- Molecular Strategies for the Discovery, Optimization, and Efficient Use of Green Pesticides (Deadline: 20 September 2026)
- Antibody Engineering and Therapeutic Applications (Deadline: 20 September 2026)
- Molecular Pharmacognosy: Bioactive Natural Products and Mechanistic Insights (Deadline: 20 September 2026)
- New Insights into Network Pharmacology (Deadline: 20 September 2026)
- Next-Generation Drug Development: Novel Modalities, AI Modeling, and Biomarkers (Deadline: 20 September 2026)
- Antitumoral Properties of Natural and Synthetic Compounds (Deadline: 20 September 2026)
- Advanced Molecular Research on Diabetes Pharmacology (Deadline: 20 September 2026)
- Research on Metal-Based Drugs and Their Mechanisms of Action (Deadline: 25 September 2026)
- Molecular Research on Cannabinoids and Cannabinoid Receptors (Deadline: 25 September 2026)
- Pharmacological Agents for Soft Tissue and Articular Injections: From Mechanisms to Clinical Applications (Deadline: 30 September 2026)
- Breaking Barriers in Drug Discovery: Novel Methodologies and Mechanisms of Action (Deadline: 30 September 2026)
- Research on Drug Delivery in Health and Disease (Deadline: 30 September 2026)
- Natural Products in Drug Discovery and Development: 2nd Edition (Deadline: 30 September 2026)
- Emerging Cardiovascular Drugs and Nutraceuticals: Mechanistic Insights, Translational Research and Clinical Impacts (Deadline: 30 September 2026)
- Pharmacological Mechanisms of Traditional Medicine in the Treatment of Pulmonary Diseases (Deadline: 30 September 2026)
- In Honor of the 76th Birthday of Dr. Rachel Mata Essayag, a Distinguished Pioneer in Natural Products Research in Mexico (Deadline: 30 September 2026)
- Pharmacological Research on Autoimmune Disease (Deadline: 30 September 2026)
- Nucleic Acid Therapeutics: From Molecular Mechanisms to Delivery, Manufacturing, and Clinical Translation (Deadline: 15 October 2026)
- Pharmacological Approaches in Inflammation, Aging, and Cardiovascular Diseases (Deadline: 20 October 2026)
- Advances in Drug Discovery: Emerging Radiotracers and Small Molecule Inhibitors for Cancer and Neurological Disorders (Deadline: 20 October 2026)
- The Role of Natural Products in Inflammation (Deadline: 23 October 2026)
- Advances in Macromolecular Drug Design and Research (Deadline: 25 October 2026)
- New Insight into the Discovery of Antiviral and Antibacterial Agents (Deadline: 30 October 2026)
- Pleiotropic Effects of Statins: Molecular Interactions and Therapeutic Potential in Human Diseases (Deadline: 30 October 2026)
- Anti-Parasitic Drugs: Mechanisms, Novel Molecules and Big Data Applications (Deadline: 30 October 2026)
- Enzymes and Enzyme Inhibitors—Applications in Medicine and Diagnosis, 3rd Edition (Deadline: 31 October 2026)
- Breaking Antimicrobial Resistance: Unraveling Mechanisms and Pioneering Control Strategies (Deadline: 31 October 2026)
- Metal Complexes: From Synthesis to Pharmacological Studies and Application (Deadline: 31 October 2026)
- Drug Toxicity and Its Impact on Disease Therapies (Deadline: 31 October 2026)
- Pharmacological Perspectives for Natural Products (Deadline: 31 October 2026)
- Beyond the Single Gene: The Polygenic Architecture of Drug Response (Deadline: 31 October 2026)
- Collagen and Lipid-Based Nanoagents/Nanoparticles: Chemical Investigation and Delivery (Deadline: 31 October 2026)
- Functional Emulsion Systems in Pharmaceutical Science: Stability, Drug Delivery, and Biocatalytic Applications (Deadline: 31 October 2026)
- Medicinal Plants and Natural Compounds in Health and Disease: Progresses, Challenges, Opportunities, 2nd Edition (Deadline: 20 November 2026)
- Advances in Photodiagnosis and Photodynamic Therapy (Deadline: 30 November 2026)
- Molecular Advances on Cannabinoid and Endocannabinoid Research, 3rd Edition (Deadline: 30 November 2026)
- Application of Natural Products in Biomedicine and Pharmacotherapy: 3rd Edition (Deadline: 30 November 2026)
- State-of-the-Art Molecular Pharmacology in Thailand (Deadline: 30 November 2026)
- Biological Applications, Theoretical Studies, Nanomedicine and Molecular Docking Studies in Drug Discovery (Deadline: 10 December 2026)
- Biocatalysis of Compounds for Pharmaceutical and Biomedical Applications (Deadline: 20 December 2026)
- Synthetic Chemistry in Drug Discovery (Deadline: 25 December 2026)
- Metallopharmaceuticals: Current Trends and Future Perspectives in Cancer Immunoediting (Deadline: 31 December 2026)
- PPAR Update: Molecular Mechanisms and Therapeutic Perspectives (Deadline: 31 December 2026)
- Design, Synthesis and Evaluations of Anticancer Activity of Multi–Target Inhibitors (Deadline: 31 December 2026)
- Azoles and Fused Heterocycles in Antimicrobial Drug Discovery: Synthesis, Mechanisms, and Applications (Deadline: 31 December 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
